MedTrace Logo

An Evaluation of Treatment of Amblyopia in Children 7 To <18 Years Old

NCT00094692 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 507

Last updated 2010-03-24

No results posted yet for this study

Summary

The goals of this study are:

* To determine the response rate of treatment of amblyopia in 7 to \<18 year olds.
* To determine the frequency of recurrence of amblyopia in 7 to \<18 year olds after discontinuation of amblyopia treatment.

Conditions

  • Amblyopia

Interventions

DEVICE

Eye patch

DEVICE

spectacles

DRUG

atropine

Sponsors & Collaborators

  • National Eye Institute (NEI)

    collaborator NIH

  • Jaeb Center for Health Research

    lead OTHER

Principal Investigators

  • Richard W. Hertle, M.D. · University of Pittsburgh

  • Mitchell M. Scheiman, O.D. · Pennsylvania College of Optometry

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
7 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-10-31
Completion
2005-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00094692 on ClinicalTrials.gov